EVOLUS INC (EOLS:NASDAQ)
$7.75 0.02 (0.2587%)
Analysed EVOLUS INC (EOLS:NASDAQ) News Sources
A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture
01-09-2026
yahoo.com
Following Heightened Competition from Botox, Xeomin, and Long-Acting Daxxify, New Study Evaluates Dysport (abobotulinumtoxinA) Revenue Trajectory Through 2034
17-08-2026
yahoo.com
UTMD Trades at a Premium to the Industry: How to Play the Stock?
08-10-2026
yahoo.com
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10-07-2026
yahoo.com
Evolus Q2 Earnings Call Highlights
06-08-2026
marketbeat.com
Evolus Inc (EOLS) (Q2 2026) Earnings Call Highlights: Revenue Surges 21% and Adjusted EBITDA ...
06-08-2026
yahoo.com
Wall Street Analysts Think Evolus (EOLS) Could Surge 77.68%: Read This Before Placing a Bet
27-08-2026
yahoo.com
Evolus (EOLS) Notches A Profit Milestone While Betting Big On The Future
09-09-2026
yahoo.com
Evolus Launches Wings by Evolus, a New Charitable Platform to Mobilize Its Community in Support of Important Causes
01-10-2026
yahoo.com
FDA Flags Evolus’ Jeuveau Instagram Promotion As Misleading, Seeks Corrective Action
02-10-2026
stocktwits.com
What is the current price of EVOLUS INC (EOLS:NASDAQ)?
The current price of EVOLUS INC (EOLS:NASDAQ) is $7.75.
EVOLUS INC (EOLS:NASDAQ) absolute price change since previous trading day?
The absolute price change of EVOLUS INC (EOLS:NASDAQ) since the previous trading day is $0.02.
EVOLUS INC (EOLS:NASDAQ) percentage price change since previous trading day?
The percentage price change of EVOLUS INC (EOLS:NASDAQ) since the previous trading day is 0.2587%.
What is the most recent average sentiment score for EVOLUS INC (EOLS:NASDAQ)?
The most recent average sentiment score for EVOLUS INC (EOLS:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for EVOLUS INC (EOLS:NASDAQ)?
The most recent sentiment for EVOLUS INC (EOLS:NASDAQ) is .
SEC-8K** Filing Available For EVOLUS INC (EOLS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.